Development of Novel Drugs for High Risk Triple Negative

Project: Research project

Description

Development of Novel Drugs for High Risk Triple Negative Breast Cancer Treatment
StatusFinished
Effective start/end date3/15/158/31/19

Funding

  • US ARMY MED RESEARCH & MATERIEL COMMAND

Fingerprint

Triple Negative Breast Neoplasms
Pharmaceutical Preparations